GlaxoSmithKline PLC (NYSE:GSK)

40.19
Delayed Data
As of Aug 16
 +0.23 / +0.58%
Today’s Change
36.41
Today|||52-Week Range
42.47
+5.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues10.5B10.5B10.0B10.0B
 
 
 
 
 
Cost of Goods Sold2.8B3.0B1.6B2.1B
 
 
 
 
 
Depreciation And Amortization646.4M764.1M1.5B997.3M
 
 
 
 
 
 
Operating ExpensesGross Income7.1B6.8B6.9B6.9B
 
 
 
 
 
General Expenses4.6B4.8B4.5B4.6B
 
 
 
 
 
Research And Development1.3B1.4B1.3B1.4B
 
 
 
 
 
Total Operating Expenses8.0B8.5B7.6B7.8B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income2.5B2.1B2.4B2.3B
 
 
 
 
 
Extraordinary Credit0.000.00110.7M0.00
 
 
Extraordinary Charge-323.2M-294.6M-494.9M-638.8M
 
 
 
 
 
Interest Expense On Debt303.6M268.9M291.7M304.6M
 
 
 
 
 
Equity In Earnings19.5M6.4M74.2M-5.1M
 
 
 
 
 
Other Expenses286.7M239.3M-134.1M260.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income2.2B1.8B1.6B1.6B
 
 
 
 
 
Income Taxes-251.5M-95.2M-403.7M-275.0M
 
 
 
 
 
Minority Interest-122.5M-109.3M-201.9M-110.5M
 
 
 
 
 
Net Income1.8B1.6B1.1B1.2B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.5B2.5B2.5B2.5B
 
 
 
 
 
Shares To Calculate EPS Diluted2.5B2.5B2.5B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$0.75$0.64$0.44$0.50
 
 
 
 
 
EPS Diluted$0.74$0.63$0.43$0.50